A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
Active, not recruiting · NCT04973163 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation | Solid Tumors, KRAS Mutation | Active, not recruiting | Phase 1 | 2026-09-30 | NCT04973163 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brussels - HOSP Jules Bordet | Anderlecht/Brussels-Capital | Belgium | 2 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 200 |
| Memorial Sloan-Kettering Cancer Center | New York | United States | 4 |
| Sarah Cannon Research Institute at Mary Crowley | Dallas | United States | 7 |
| The Christie Hospital | Manchester | United Kingdom | 27 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Universitair Ziekenhuis Antwerpen | Edegem/Antwerpen | Belgium | 1 |
| Universitair Ziekenhuis Gent | Gent/Oost-Vlaanderen | Belgium | 1 |
| UZ Leuven | Leuven/Vlaams-Brabant | Belgium | 1 |